Enveric Biosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised
Discontinued › Balance Sheet › Equity › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised · last filed 2020-08-12
- Enveric Biosciences, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2019 was 902.79K shares, a 15.82% increase from fiscal 2018.
- Enveric Biosciences, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2018 was 779.45K shares, a 1069.16% increase from fiscal 2017.
- Enveric Biosciences, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2017 was 66.67K shares, a 1400.16% increase from fiscal 2016.
- Enveric Biosciences, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2016 was 4.44K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 12 month |
|---|---|
| 2019-12-31 | 902.79K shares 10-K/A · filed 2020-08-12 |
| 2018-12-31 | 779.45K shares 10-K/A · filed 2020-08-12 |
| 2017-12-31 | 66.67K shares 10-K/A · filed 2020-08-12 |
| 2016-12-31 | 4.44K shares 10-K/A · filed 2020-08-12 |